FTC Bans Geniux Dietary Supplement Sellers from Making False Efficacy Claims

966
SHARE
FTC bans Geniux sellers false efficacy claims

The Federal Trade Commission (FTC) prohibited the sellers of cognitive dietary supplements including Geniux, Xcel, EVO, and Ion-Z from making false claims regarding the efficacy of these products.

The FTC ordered the ban against 12 corporate and four individual defendants accused of engaging in deceptive marketing practices.

The corporate defendants include Global Community Innovations, Innovated Health, Emerging Nutrition, Premium Health Supplies, Buddha My Bread, Innovated Fulfillment, Ship Smart, Vista Media, Ash Abbas, DCT Marketing, RNA Enterprise, and Ros Marketing.

The individual defendants are Fred Guerra, III; Lanty Paul Gray, Jr., Rafat Abbas, and Robby Salaheddin. They serve as officer or member of the companies mentioned above.

Geniux sellers violated the FTC Act

In the complaint, the FTC alleged that the defendants made false and unsubstantiated efficacy claims about its Geniux products. They allegedly used non-existent clinical studies and fake consumer endorsements to attract consumers to buy their cognitive dietary supplements, which costs between $47 and $57 per bottle.